pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,330 catalysts · 6,086 phase readout · 2,238 8k filing · 395 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout6,086
  • 8k filing2,238
  • earnings395
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

30
›COMPLETEDphase readoutNCT04290741: Emergency Department Acupuncture for Acute Musculoskeletal Pain Management

Sponsor: Duke University. Phase: NA. Conditions: Musculoskeletal Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT00912041: BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

Sponsor: Leigh R. Hochberg, MD, PhD.. Phase: NA. Conditions: Tetraplegia, Spinal Cord Injuries, Amyotrophic Lateral Sclerosis, Brain Stem Infarctions, Locked in Syndrome, Muscular Dystrophy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02324387: Tc99m Sestamibi Molecular Breast Imaging

Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Breast Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT06307093: Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms

Sponsor: R-Pharm. Phase: PHASE1. Conditions: Skin Melanoma, Squamous Non-small-cell Lung Cancer, Head and Neck Squamous Cell Carcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT04463121: Preload and Autonomic Responses With Cardiac Neuromodulation Therapy (CNT) (CS-06)

Sponsor: BackBeat Medical Inc. Phase: NA. Conditions: Bradycardia, Hypertension, Systolic

full page →ctgov ↗
›COMPLETEDphase readoutNCT07017621: Qualitative Study on the Experiences of Mothers 6 to 12 Months After Their Participation in the Mother-baby Groups of the HUGS Study

Sponsor: University Hospital, Toulouse. Phase: . Conditions: Postnatal Depression, Postpartum Depression (PPD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06368414: A Study of Treatment-free Remission in Chronic Phase Chronic Myeloid Leukemia

Sponsor: Korean Society of Hematology. Phase: PHASE2. Conditions: Chronic Myeloid Leukemia, Chronic Phase

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05711316: The BD Liverty™ TIPS Stent Graft Study

Sponsor: C. R. Bard. Phase: NA. Conditions: Portal Hypertension, TIPS

full page →ctgov ↗
›COMPLETEDphase readoutNCT07455825: A Study to Investigate the Pharmacokinetics of Different Formulations and Safety of AZD5004 in Healthy Participants Aged 18 to 55 Years

Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Healthy Participants

full page →ctgov ↗
›COMPLETEDphase readoutNCT07700576: Effects of Different Nap Durations on Volleyball Performance and EEG Activity Following Mental Fatigue

Sponsor: Inonu University. Phase: NA. Conditions: Mental Fatigue, Recovery, Volleyball, Sport Performance

full page →ctgov ↗
›RECRUITINGphase readoutNCT07687576: Comparative Evaluation of Sustained meChanical AsPiration Thrombectomy and no Thrombus Modification for Pre-stent Thrombus bUrden Reduction in Patients With Acute Myocardial Infarction Study: the CAPTURE AMI Study

Sponsor: Oxford University Hospitals NHS Trust. Phase: PHASE2. Conditions: STEMI - ST Elevation Myocardial Infarction

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07505576: Anti-alpha-actinin Antibodies and Lupus Nephritis Activity

Sponsor: Assiut University. Phase: . Conditions: Lupus Nephritis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06090240: Motivational Interviewing to Enhance Advance Care Planning for Older Adults and Caregivers After Emergency Visits

Sponsor: The University of Hong Kong. Phase: NA. Conditions: Older Adults, Advance Care Planning, Advance Directives, Family Members

full page →ctgov ↗
›RECRUITINGphase readoutNCT05636540: In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma

Sponsor: Heather Wachtel. Phase: EARLY_PHASE1. Conditions: Pheochromocytoma, Paraganglioma

full page →ctgov ↗
›COMPLETEDphase readoutNCT07720440: Nociception Level Index Monitoring During Cesarean Section

Sponsor: Istinye University. Phase: NA. Conditions: Cesarean Section, Postoperative Pain After Cesarean Section, Pain Management

full page →ctgov ↗
›COMPLETEDphase readoutNCT06454240: A Proof-of-concept Study of Lunsekimig Compared With Placebo in Adults With Chronic Rhinosinusitis With Nasal Polyps

Sponsor: Sanofi. Phase: PHASE2. Conditions: Chronic Rhinosinusitis With Nasal Polyps

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07593040: Pembrolizumab Plus Belzutifan With or Without Lenvatinib in Localized Renal Cell Carcinoma

Sponsor: Vall d'Hebron Institute of Oncology. Phase: PHASE2. Conditions: Renal Cell Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT05745389: CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry

Sponsor: CorEvitas. Phase: . Conditions: Alopecia Areata

full page →ctgov ↗
›COMPLETEDphase readoutNCT07723989: Gamified Program in Primary School Physical Education

Sponsor: University of Jaén. Phase: NA. Conditions: Physical Activity

full page →ctgov ↗
›RECRUITINGphase readoutNCT07370389: The Analgesic Efficacy and Safety of Tulodesvenlafaxine in Patients With Herpes Zoster

Sponsor: Beijing Tiantan Hospital. Phase: NA. Conditions: Herpes Zoster, Pain

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT00637689: Improving Outcomes Assessment in Chronic GVHD

Sponsor: Fred Hutchinson Cancer Center. Phase: . Conditions: Chronic Graft Versus Host Disease

full page →ctgov ↗
›TERMINATEDphase readoutNCT04095689: Docetaxel Chemotherapy and Pembrolizumab Plus Interleukin-12 Gene Therapy in Triple Negative Breast Cancer

Sponsor: The Methodist Hospital Research Institute. Phase: PHASE2. Conditions: Triple Negative Breast Cancer, Anthracycline-refractory TNBC

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06280989: Effect of Kinesio Taping Versus Myofascial Release on Menstrual Low Back Pain

Sponsor: Cairo University. Phase: NA. Conditions: Low Back Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT06000943: Ischemic And Bleeding Risk Assessment After TAVR

Sponsor: Niguarda Hospital. Phase: . Conditions: Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement

full page →ctgov ↗
›COMPLETEDphase readoutNCT03709043: Addressing Heavy Alcohol Use Consumption With Kudzu

Sponsor: Glenn-Milo Santos. Phase: PHASE2. Conditions: Alcohol Use Disorder, Sexually Transmitted Diseases

full page →ctgov ↗
›COMPLETEDphase readoutNCT05888415: WELL-being Improvement Following Sophrology Practice

Sponsor: University Hospital, Clermont-Ferrand. Phase: . Conditions: Well-being

full page →ctgov ↗
›TERMINATEDphase readoutNCT04504435: Safety, Tolerability and Pharmacokinetics (PK) Investigation of GSK3494245 in Healthy Participants

Sponsor: GlaxoSmithKline. Phase: PHASE1. Conditions: Leishmaniasis

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06788925: Clinical Evaluation of Effectiveness of the "Therm'Up" Heating Device

Sponsor: ThermoTrauma. Phase: NA. Conditions: Hypothermia Due to Cold Environment

full page →ctgov ↗
›COMPLETEDphase readoutNCT06904976: Nature-based Contemplation and Spiritual Well-being Among Adults With Moderate Prolonged Grief Symptoms

Sponsor: University of Twente. Phase: NA. Conditions: Grief, Spiritual Wellbeing

full page →ctgov ↗
›RECRUITINGphase readoutNCT07378176: Prognosis of Primary Aldosteronism: A Prospective Cohort Study

Sponsor: Xinjiang Medical University. Phase: . Conditions: Primary Aldosteronism

full page →ctgov ↗
← prev
page 167 of 167
next →